Company name |
Beschreibung |
|---|---|
| Parabon Computation, Inc. |
If you have a computer with Internet access, you can help fight cancer, and it won´t cost you a thing. Simply download the Frontier® Compute Engine to become a Parabon provider, and bring new hope to cancer patients and their families. |
| Panomics |
Panomics, Inc. and the postgenomic era. We develop innovative research tools to explore postgenomic frontiers. |
| PamGene |
Biomarker company, focused on new opportunities for the development of Personalized Medicine |
| Pacific Biosciences |
Transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. |
| Oxford Gene Technology |
Genetics and Biomarker Solutions |
| Oxagen Ltd |
Small molecule drugs addressing asthma and other chronic allergic and inflammatory conditions |
| Otava Ltd. |
Synthetic organic compounds for research and drug discovery |
| Orphagen Pharmaceuticals |
Drug discovery to treat diseases |
| Orion Genomics |
Research tools and molecular diagnostic products |
| OriGene Technologies, Inc. |
Collection of full-length human cDNAs in a standard expression vector. |
| OriGene |
Gene centric lifescience tools |
| Optimal Design |
Data Analysis |
| OpGen Incorporated |
Genome Mapping |
| OpenEye Scientific Software |
Software for molecular modeling and cheminformatics |
| OpenClinica |
Open source clinical trials software |
| OligoEngine |
RNAi design, Asymmetric shRNA, and X-miR MicroRNA repressors for research |
| Odyssey Thera |
Drug discovery company with a cellular pharmacology strategy for the identification of safe and effective medicines for a wide spectrum of human diseases. |
| Ocimum Biosolutions |
Genomics outsourcing partner |
| Numerical Algorithms Group |
Numerical, symbolic, statistical, visualisation and simulation software for the solution of problems in such areas as science, engineering, financial analysis and research. |
| NOXXON Pharma AG |
Proprietary therapeutics called Spiegelmers, the chemically synthesized, non-immunogenic alternative to antibodies |